nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1A2—Pentoxifylline—systemic scleroderma	0.063	0.251	CbGbCtD
Melatonin—CYP1A2—Leflunomide—systemic scleroderma	0.0601	0.239	CbGbCtD
Melatonin—CYP2C9—Leflunomide—systemic scleroderma	0.0541	0.215	CbGbCtD
Melatonin—SLC22A8—Methotrexate—systemic scleroderma	0.042	0.167	CbGbCtD
Melatonin—CYP2C19—Prednisone—systemic scleroderma	0.0322	0.128	CbGbCtD
Melatonin—CYP2C9—cardial valve—systemic scleroderma	0.0226	0.107	CbGeAlD
Melatonin—IDO1—connective tissue—systemic scleroderma	0.0102	0.0484	CbGeAlD
Melatonin—EPX—digestive system—systemic scleroderma	0.00974	0.0461	CbGeAlD
Melatonin—EPX—lung—systemic scleroderma	0.00813	0.0385	CbGeAlD
Melatonin—ASMT—digestive system—systemic scleroderma	0.00807	0.0382	CbGeAlD
Melatonin—IDO1—digestive system—systemic scleroderma	0.00738	0.035	CbGeAlD
Melatonin—MPO—artery—systemic scleroderma	0.00651	0.0308	CbGeAlD
Melatonin—IDO1—lung—systemic scleroderma	0.00616	0.0292	CbGeAlD
Melatonin—CALR—connective tissue—systemic scleroderma	0.00599	0.0284	CbGeAlD
Melatonin—MPO—endothelium—systemic scleroderma	0.0055	0.0261	CbGeAlD
Melatonin—CALR—smooth muscle tissue—systemic scleroderma	0.00548	0.026	CbGeAlD
Melatonin—CALR—skin of body—systemic scleroderma	0.00541	0.0256	CbGeAlD
Melatonin—MPO—blood vessel—systemic scleroderma	0.00507	0.024	CbGeAlD
Melatonin—CALM2—artery—systemic scleroderma	0.0046	0.0218	CbGeAlD
Melatonin—MT3—lung—systemic scleroderma	0.00458	0.0217	CbGeAlD
Melatonin—CALM1—artery—systemic scleroderma	0.00458	0.0217	CbGeAlD
Melatonin—CALR—digestive system—systemic scleroderma	0.00433	0.0205	CbGeAlD
Melatonin—CALR—tendon—systemic scleroderma	0.00412	0.0195	CbGeAlD
Melatonin—CALM2—endothelium—systemic scleroderma	0.00388	0.0184	CbGeAlD
Melatonin—CALM1—endothelium—systemic scleroderma	0.00386	0.0183	CbGeAlD
Melatonin—CALR—lung—systemic scleroderma	0.00361	0.0171	CbGeAlD
Melatonin—ESR1—blood vessel—systemic scleroderma	0.0036	0.0171	CbGeAlD
Melatonin—CALM2—blood vessel—systemic scleroderma	0.00358	0.017	CbGeAlD
Melatonin—CALM1—blood vessel—systemic scleroderma	0.00356	0.0169	CbGeAlD
Melatonin—MPO—connective tissue—systemic scleroderma	0.0026	0.0123	CbGeAlD
Melatonin—MPO—skin of body—systemic scleroderma	0.00235	0.0111	CbGeAlD
Melatonin—NQO2—tendon—systemic scleroderma	0.00232	0.011	CbGeAlD
Melatonin—CALM3—smooth muscle tissue—systemic scleroderma	0.00214	0.0101	CbGeAlD
Melatonin—CYP19A1—connective tissue—systemic scleroderma	0.00213	0.0101	CbGeAlD
Melatonin—NQO2—lung—systemic scleroderma	0.00204	0.00966	CbGeAlD
Melatonin—CYP1B1—connective tissue—systemic scleroderma	0.00199	0.00941	CbGeAlD
Melatonin—MPO—digestive system—systemic scleroderma	0.00188	0.0089	CbGeAlD
Melatonin—ESR1—connective tissue—systemic scleroderma	0.00185	0.00875	CbGeAlD
Melatonin—CALM2—connective tissue—systemic scleroderma	0.00184	0.0087	CbGeAlD
Melatonin—CALM1—connective tissue—systemic scleroderma	0.00183	0.00866	CbGeAlD
Melatonin—CYP1B1—smooth muscle tissue—systemic scleroderma	0.00182	0.00861	CbGeAlD
Melatonin—CYP1B1—skin of body—systemic scleroderma	0.00179	0.0085	CbGeAlD
Melatonin—ESR1—smooth muscle tissue—systemic scleroderma	0.00169	0.008	CbGeAlD
Melatonin—CALM2—smooth muscle tissue—systemic scleroderma	0.00168	0.00796	CbGeAlD
Melatonin—CALM1—smooth muscle tissue—systemic scleroderma	0.00167	0.00792	CbGeAlD
Melatonin—CALM2—skin of body—systemic scleroderma	0.00166	0.00785	CbGeAlD
Melatonin—CALM1—skin of body—systemic scleroderma	0.00165	0.00782	CbGeAlD
Melatonin—CALM3—tendon—systemic scleroderma	0.00161	0.00761	CbGeAlD
Melatonin—MPO—lung—systemic scleroderma	0.00157	0.00743	CbGeAlD
Melatonin—CYP1B1—digestive system—systemic scleroderma	0.00143	0.0068	CbGeAlD
Melatonin—CALM3—lung—systemic scleroderma	0.00141	0.00668	CbGeAlD
Melatonin—CYP1B1—tendon—systemic scleroderma	0.00137	0.00647	CbGeAlD
Melatonin—ESR1—digestive system—systemic scleroderma	0.00133	0.00632	CbGeAlD
Melatonin—CALM2—digestive system—systemic scleroderma	0.00133	0.00628	CbGeAlD
Melatonin—CALM1—digestive system—systemic scleroderma	0.00132	0.00625	CbGeAlD
Melatonin—CYP1A1—skin of body—systemic scleroderma	0.00127	0.00601	CbGeAlD
Melatonin—CALM2—tendon—systemic scleroderma	0.00126	0.00598	CbGeAlD
Melatonin—CYP2C19—digestive system—systemic scleroderma	0.00126	0.00596	CbGeAlD
Melatonin—CALM1—tendon—systemic scleroderma	0.00126	0.00595	CbGeAlD
Melatonin—CYP1B1—lung—systemic scleroderma	0.0012	0.00568	CbGeAlD
Melatonin—ESR1—lung—systemic scleroderma	0.00111	0.00528	CbGeAlD
Melatonin—CALM2—lung—systemic scleroderma	0.00111	0.00525	CbGeAlD
Melatonin—CALM1—lung—systemic scleroderma	0.0011	0.00522	CbGeAlD
Melatonin—CYP1A2—digestive system—systemic scleroderma	0.00103	0.00487	CbGeAlD
Melatonin—CYP1A1—digestive system—systemic scleroderma	0.00101	0.00481	CbGeAlD
Melatonin—CYP2C9—digestive system—systemic scleroderma	0.000976	0.00462	CbGeAlD
Melatonin—CYP1A2—lung—systemic scleroderma	0.000859	0.00407	CbGeAlD
Melatonin—CYP1A1—lung—systemic scleroderma	0.000847	0.00401	CbGeAlD
Melatonin—Infection—Leflunomide—systemic scleroderma	0.000626	0.00158	CcSEcCtD
Melatonin—Vision blurred—Lisinopril—systemic scleroderma	0.000625	0.00158	CcSEcCtD
Melatonin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000625	0.00158	CcSEcCtD
Melatonin—Anxiety—Mycophenolic acid—systemic scleroderma	0.000625	0.00158	CcSEcCtD
Melatonin—Asthenia—Mometasone—systemic scleroderma	0.000625	0.00157	CcSEcCtD
Melatonin—Irritability—Prednisone—systemic scleroderma	0.000625	0.00157	CcSEcCtD
Melatonin—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000624	0.00157	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000623	0.00157	CcSEcCtD
Melatonin—Polyuria—Methotrexate—systemic scleroderma	0.000623	0.00157	CcSEcCtD
Melatonin—Mood swings—Prednisone—systemic scleroderma	0.00062	0.00156	CcSEcCtD
Melatonin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00062	0.00156	CcSEcCtD
Melatonin—Nervous system disorder—Leflunomide—systemic scleroderma	0.000618	0.00156	CcSEcCtD
Melatonin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000617	0.00156	CcSEcCtD
Melatonin—Pruritus—Mometasone—systemic scleroderma	0.000616	0.00155	CcSEcCtD
Melatonin—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000613	0.00155	CcSEcCtD
Melatonin—Skin disorder—Leflunomide—systemic scleroderma	0.000612	0.00154	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000608	0.00153	CcSEcCtD
Melatonin—Angioedema—Lisinopril—systemic scleroderma	0.000606	0.00153	CcSEcCtD
Melatonin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000606	0.00153	CcSEcCtD
Melatonin—Abdominal pain—Captopril—systemic scleroderma	0.000604	0.00152	CcSEcCtD
Melatonin—Dry skin—Prednisone—systemic scleroderma	0.0006	0.00151	CcSEcCtD
Melatonin—Nausea—Pentoxifylline—systemic scleroderma	0.000599	0.00151	CcSEcCtD
Melatonin—Infection—Mycophenolic acid—systemic scleroderma	0.000597	0.00151	CcSEcCtD
Melatonin—Vertigo—Lisinopril—systemic scleroderma	0.000596	0.0015	CcSEcCtD
Melatonin—Syncope—Lisinopril—systemic scleroderma	0.000595	0.0015	CcSEcCtD
Melatonin—Leukopenia—Lisinopril—systemic scleroderma	0.000594	0.0015	CcSEcCtD
Melatonin—Shock—Mycophenolic acid—systemic scleroderma	0.000591	0.00149	CcSEcCtD
Melatonin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00059	0.00149	CcSEcCtD
Melatonin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000589	0.00148	CcSEcCtD
Melatonin—Palpitations—Lisinopril—systemic scleroderma	0.000586	0.00148	CcSEcCtD
Melatonin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00147	CcSEcCtD
Melatonin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000584	0.00147	CcSEcCtD
Melatonin—Loss of consciousness—Lisinopril—systemic scleroderma	0.000583	0.00147	CcSEcCtD
Melatonin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000581	0.00147	CcSEcCtD
Melatonin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000576	0.00145	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000574	0.00145	CcSEcCtD
Melatonin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000573	0.00144	CcSEcCtD
Melatonin—Tension—Mycophenolate mofetil—systemic scleroderma	0.00057	0.00144	CcSEcCtD
Melatonin—Insomnia—Leflunomide—systemic scleroderma	0.00057	0.00144	CcSEcCtD
Melatonin—Paraesthesia—Leflunomide—systemic scleroderma	0.000566	0.00143	CcSEcCtD
Melatonin—Chest pain—Lisinopril—systemic scleroderma	0.000565	0.00142	CcSEcCtD
Melatonin—Arthralgia—Lisinopril—systemic scleroderma	0.000565	0.00142	CcSEcCtD
Melatonin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00142	CcSEcCtD
Melatonin—Anxiety—Lisinopril—systemic scleroderma	0.000563	0.00142	CcSEcCtD
Melatonin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00142	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000561	0.00141	CcSEcCtD
Melatonin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000559	0.00141	CcSEcCtD
Melatonin—Lethargy—Methotrexate—systemic scleroderma	0.000558	0.00141	CcSEcCtD
Melatonin—Dyspepsia—Leflunomide—systemic scleroderma	0.000555	0.0014	CcSEcCtD
Melatonin—Vomiting—Mometasone—systemic scleroderma	0.000554	0.0014	CcSEcCtD
Melatonin—Dry mouth—Lisinopril—systemic scleroderma	0.000552	0.00139	CcSEcCtD
Melatonin—Rash—Mometasone—systemic scleroderma	0.000549	0.00138	CcSEcCtD
Melatonin—Asthenia—Captopril—systemic scleroderma	0.000549	0.00138	CcSEcCtD
Melatonin—Dermatitis—Mometasone—systemic scleroderma	0.000548	0.00138	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000548	0.00138	CcSEcCtD
Melatonin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000546	0.00138	CcSEcCtD
Melatonin—Headache—Mometasone—systemic scleroderma	0.000545	0.00137	CcSEcCtD
Melatonin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000544	0.00137	CcSEcCtD
Melatonin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000544	0.00137	CcSEcCtD
Melatonin—Fatigue—Leflunomide—systemic scleroderma	0.000543	0.00137	CcSEcCtD
Melatonin—Pruritus—Captopril—systemic scleroderma	0.000541	0.00136	CcSEcCtD
Melatonin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00054	0.00136	CcSEcCtD
Melatonin—Pain—Leflunomide—systemic scleroderma	0.000539	0.00136	CcSEcCtD
Melatonin—Infection—Lisinopril—systemic scleroderma	0.000538	0.00136	CcSEcCtD
Melatonin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000534	0.00135	CcSEcCtD
Melatonin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000534	0.00135	CcSEcCtD
Melatonin—Shock—Lisinopril—systemic scleroderma	0.000533	0.00134	CcSEcCtD
Melatonin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00134	CcSEcCtD
Melatonin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00053	0.00134	CcSEcCtD
Melatonin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000529	0.00133	CcSEcCtD
Melatonin—Abdominal pain—Azathioprine—systemic scleroderma	0.000528	0.00133	CcSEcCtD
Melatonin—Skin disorder—Lisinopril—systemic scleroderma	0.000526	0.00133	CcSEcCtD
Melatonin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00132	CcSEcCtD
Melatonin—Irritability—Methotrexate—systemic scleroderma	0.000522	0.00132	CcSEcCtD
Melatonin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00131	CcSEcCtD
Melatonin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00131	CcSEcCtD
Melatonin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000519	0.00131	CcSEcCtD
Melatonin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000518	0.00131	CcSEcCtD
Melatonin—Mood swings—Methotrexate—systemic scleroderma	0.000518	0.00131	CcSEcCtD
Melatonin—Nausea—Mometasone—systemic scleroderma	0.000517	0.0013	CcSEcCtD
Melatonin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000515	0.0013	CcSEcCtD
Melatonin—Weight increased—Prednisone—systemic scleroderma	0.000515	0.0013	CcSEcCtD
Melatonin—Pain—Mycophenolic acid—systemic scleroderma	0.000514	0.0013	CcSEcCtD
Melatonin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000514	0.00129	CcSEcCtD
Melatonin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00129	CcSEcCtD
Melatonin—Dizziness—Captopril—systemic scleroderma	0.000506	0.00127	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000505	0.00127	CcSEcCtD
Melatonin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00126	CcSEcCtD
Melatonin—Abdominal pain—Leflunomide—systemic scleroderma	0.000498	0.00126	CcSEcCtD
Melatonin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00125	CcSEcCtD
Melatonin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00125	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—systemic scleroderma	0.000494	0.00125	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000493	0.00124	CcSEcCtD
Melatonin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00124	CcSEcCtD
Melatonin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000492	0.00124	CcSEcCtD
Melatonin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000492	0.00124	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00124	CcSEcCtD
Melatonin—Insomnia—Lisinopril—systemic scleroderma	0.00049	0.00123	CcSEcCtD
Melatonin—Paraesthesia—Lisinopril—systemic scleroderma	0.000486	0.00123	CcSEcCtD
Melatonin—Vomiting—Captopril—systemic scleroderma	0.000486	0.00123	CcSEcCtD
Melatonin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00122	CcSEcCtD
Melatonin—Rash—Captopril—systemic scleroderma	0.000482	0.00122	CcSEcCtD
Melatonin—Dermatitis—Captopril—systemic scleroderma	0.000482	0.00121	CcSEcCtD
Melatonin—Somnolence—Lisinopril—systemic scleroderma	0.000481	0.00121	CcSEcCtD
Melatonin—Headache—Captopril—systemic scleroderma	0.000479	0.00121	CcSEcCtD
Melatonin—Dyspepsia—Lisinopril—systemic scleroderma	0.000477	0.0012	CcSEcCtD
Melatonin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000475	0.0012	CcSEcCtD
Melatonin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000471	0.00119	CcSEcCtD
Melatonin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000468	0.00118	CcSEcCtD
Melatonin—Fatigue—Lisinopril—systemic scleroderma	0.000467	0.00118	CcSEcCtD
Melatonin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00118	CcSEcCtD
Melatonin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00117	CcSEcCtD
Melatonin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00117	CcSEcCtD
Melatonin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000464	0.00117	CcSEcCtD
Melatonin—Pain—Lisinopril—systemic scleroderma	0.000463	0.00117	CcSEcCtD
Melatonin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00116	CcSEcCtD
Melatonin—Nausea—Captopril—systemic scleroderma	0.000454	0.00114	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000453	0.00114	CcSEcCtD
Melatonin—Asthenia—Leflunomide—systemic scleroderma	0.000452	0.00114	CcSEcCtD
Melatonin—Pruritus—Leflunomide—systemic scleroderma	0.000446	0.00112	CcSEcCtD
Melatonin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000445	0.00112	CcSEcCtD
Melatonin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000443	0.00112	CcSEcCtD
Melatonin—Dizziness—Azathioprine—systemic scleroderma	0.000441	0.00111	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00109	CcSEcCtD
Melatonin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000431	0.00109	CcSEcCtD
Melatonin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00108	CcSEcCtD
Melatonin—Abdominal pain—Lisinopril—systemic scleroderma	0.000428	0.00108	CcSEcCtD
Melatonin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00107	CcSEcCtD
Melatonin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000425	0.00107	CcSEcCtD
Melatonin—Vomiting—Azathioprine—systemic scleroderma	0.000424	0.00107	CcSEcCtD
Melatonin—Eye disorder—Prednisone—systemic scleroderma	0.000423	0.00107	CcSEcCtD
Melatonin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000422	0.00106	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—systemic scleroderma	0.000421	0.00106	CcSEcCtD
Melatonin—Infestation—Methotrexate—systemic scleroderma	0.000421	0.00106	CcSEcCtD
Melatonin—Rash—Azathioprine—systemic scleroderma	0.000421	0.00106	CcSEcCtD
Melatonin—Dermatitis—Azathioprine—systemic scleroderma	0.00042	0.00106	CcSEcCtD
Melatonin—Headache—Azathioprine—systemic scleroderma	0.000418	0.00105	CcSEcCtD
Melatonin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000418	0.00105	CcSEcCtD
Melatonin—Dizziness—Leflunomide—systemic scleroderma	0.000417	0.00105	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—systemic scleroderma	0.000411	0.00104	CcSEcCtD
Melatonin—Angiopathy—Prednisone—systemic scleroderma	0.000411	0.00104	CcSEcCtD
Melatonin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00103	CcSEcCtD
Melatonin—Immune system disorder—Prednisone—systemic scleroderma	0.000409	0.00103	CcSEcCtD
Melatonin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000406	0.00102	CcSEcCtD
Melatonin—Haematuria—Methotrexate—systemic scleroderma	0.000402	0.00101	CcSEcCtD
Melatonin—Vomiting—Leflunomide—systemic scleroderma	0.000401	0.00101	CcSEcCtD
Melatonin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000399	0.00101	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000399	0.001	CcSEcCtD
Melatonin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000398	0.001	CcSEcCtD
Melatonin—Rash—Leflunomide—systemic scleroderma	0.000397	0.001	CcSEcCtD
Melatonin—Dermatitis—Leflunomide—systemic scleroderma	0.000397	0.001	CcSEcCtD
Melatonin—Mental disorder—Prednisone—systemic scleroderma	0.000397	0.000999	CcSEcCtD
Melatonin—Nausea—Azathioprine—systemic scleroderma	0.000396	0.000999	CcSEcCtD
Melatonin—Headache—Leflunomide—systemic scleroderma	0.000395	0.000995	CcSEcCtD
Melatonin—Erythema—Prednisone—systemic scleroderma	0.000394	0.000993	CcSEcCtD
Melatonin—Malnutrition—Prednisone—systemic scleroderma	0.000394	0.000993	CcSEcCtD
Melatonin—Asthenia—Lisinopril—systemic scleroderma	0.000389	0.000979	CcSEcCtD
Melatonin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000978	CcSEcCtD
Melatonin—Pruritus—Lisinopril—systemic scleroderma	0.000383	0.000966	CcSEcCtD
Melatonin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000382	0.000963	CcSEcCtD
Melatonin—Rash—Mycophenolic acid—systemic scleroderma	0.000379	0.000955	CcSEcCtD
Melatonin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000379	0.000954	CcSEcCtD
Melatonin—Headache—Mycophenolic acid—systemic scleroderma	0.000377	0.000949	CcSEcCtD
Melatonin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000945	CcSEcCtD
Melatonin—Nausea—Leflunomide—systemic scleroderma	0.000374	0.000943	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000374	0.000942	CcSEcCtD
Melatonin—Vision blurred—Prednisone—systemic scleroderma	0.000371	0.000936	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—systemic scleroderma	0.000371	0.000935	CcSEcCtD
Melatonin—Agitation—Prednisone—systemic scleroderma	0.000362	0.000913	CcSEcCtD
Melatonin—Angioedema—Prednisone—systemic scleroderma	0.00036	0.000907	CcSEcCtD
Melatonin—Dizziness—Lisinopril—systemic scleroderma	0.000358	0.000902	CcSEcCtD
Melatonin—Nausea—Mycophenolic acid—systemic scleroderma	0.000357	0.0009	CcSEcCtD
Melatonin—Vertigo—Prednisone—systemic scleroderma	0.000354	0.000892	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—systemic scleroderma	0.000354	0.000891	CcSEcCtD
Melatonin—Syncope—Prednisone—systemic scleroderma	0.000353	0.000891	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000351	0.000885	CcSEcCtD
Melatonin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000881	CcSEcCtD
Melatonin—Loss of consciousness—Prednisone—systemic scleroderma	0.000346	0.000873	CcSEcCtD
Melatonin—Vomiting—Lisinopril—systemic scleroderma	0.000344	0.000868	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—systemic scleroderma	0.000343	0.000865	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—systemic scleroderma	0.000342	0.000861	CcSEcCtD
Melatonin—Rash—Lisinopril—systemic scleroderma	0.000341	0.00086	CcSEcCtD
Melatonin—Dermatitis—Lisinopril—systemic scleroderma	0.000341	0.00086	CcSEcCtD
Melatonin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00034	0.000858	CcSEcCtD
Melatonin—Hypertension—Prednisone—systemic scleroderma	0.00034	0.000857	CcSEcCtD
Melatonin—Headache—Lisinopril—systemic scleroderma	0.000339	0.000855	CcSEcCtD
Melatonin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000846	CcSEcCtD
Melatonin—Arthralgia—Prednisone—systemic scleroderma	0.000335	0.000846	CcSEcCtD
Melatonin—Anxiety—Prednisone—systemic scleroderma	0.000334	0.000843	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000333	0.00084	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—systemic scleroderma	0.000331	0.000835	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—systemic scleroderma	0.000329	0.00083	CcSEcCtD
Melatonin—Erythema—Methotrexate—systemic scleroderma	0.000329	0.00083	CcSEcCtD
Melatonin—Nausea—Lisinopril—systemic scleroderma	0.000322	0.000811	CcSEcCtD
Melatonin—Infection—Prednisone—systemic scleroderma	0.00032	0.000805	CcSEcCtD
Melatonin—Back pain—Methotrexate—systemic scleroderma	0.000319	0.000803	CcSEcCtD
Melatonin—Shock—Prednisone—systemic scleroderma	0.000316	0.000797	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—systemic scleroderma	0.000315	0.000795	CcSEcCtD
Melatonin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000791	CcSEcCtD
Melatonin—Skin disorder—Prednisone—systemic scleroderma	0.000312	0.000787	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—systemic scleroderma	0.00031	0.000782	CcSEcCtD
Melatonin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00076	CcSEcCtD
Melatonin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000754	CcSEcCtD
Melatonin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000753	CcSEcCtD
Melatonin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000749	CcSEcCtD
Melatonin—Vertigo—Methotrexate—systemic scleroderma	0.000296	0.000746	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—systemic scleroderma	0.000295	0.000743	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000293	0.000738	CcSEcCtD
Melatonin—Insomnia—Prednisone—systemic scleroderma	0.000291	0.000733	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—systemic scleroderma	0.000289	0.000728	CcSEcCtD
Melatonin—Dyspepsia—Prednisone—systemic scleroderma	0.000283	0.000713	CcSEcCtD
Melatonin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00071	CcSEcCtD
Melatonin—Chest pain—Methotrexate—systemic scleroderma	0.00028	0.000707	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—systemic scleroderma	0.00028	0.000707	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000278	0.000702	CcSEcCtD
Melatonin—Fatigue—Prednisone—systemic scleroderma	0.000277	0.000699	CcSEcCtD
Melatonin—Infection—Methotrexate—systemic scleroderma	0.000267	0.000673	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000264	0.000664	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000263	0.000663	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000263	0.000663	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—systemic scleroderma	0.000261	0.000658	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—systemic scleroderma	0.000254	0.000641	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000245	0.000617	CcSEcCtD
Melatonin—Insomnia—Methotrexate—systemic scleroderma	0.000243	0.000613	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—systemic scleroderma	0.000241	0.000608	CcSEcCtD
Melatonin—Somnolence—Methotrexate—systemic scleroderma	0.000239	0.000602	CcSEcCtD
Melatonin—Hypersensitivity—Prednisone—systemic scleroderma	0.000237	0.000597	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—systemic scleroderma	0.000237	0.000596	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000232	0.000585	CcSEcCtD
Melatonin—Fatigue—Methotrexate—systemic scleroderma	0.000232	0.000584	CcSEcCtD
Melatonin—Asthenia—Prednisone—systemic scleroderma	0.000231	0.000582	CcSEcCtD
Melatonin—Pain—Methotrexate—systemic scleroderma	0.00023	0.000579	CcSEcCtD
Melatonin—Pruritus—Prednisone—systemic scleroderma	0.000228	0.000573	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00022	0.000554	CcSEcCtD
Melatonin—Dizziness—Prednisone—systemic scleroderma	0.000213	0.000536	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—systemic scleroderma	0.000212	0.000535	CcSEcCtD
Melatonin—Vomiting—Prednisone—systemic scleroderma	0.000204	0.000515	CcSEcCtD
Melatonin—Rash—Prednisone—systemic scleroderma	0.000203	0.000511	CcSEcCtD
Melatonin—Dermatitis—Prednisone—systemic scleroderma	0.000203	0.000511	CcSEcCtD
Melatonin—Headache—Prednisone—systemic scleroderma	0.000201	0.000508	CcSEcCtD
Melatonin—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—systemic scleroderma	0.000201	0.00143	CbGpPWpGaD
Melatonin—CALR—Metabolism of proteins—MMP2—systemic scleroderma	0.000199	0.00141	CbGpPWpGaD
Melatonin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000198	0.000499	CcSEcCtD
Melatonin—ESR1—Regulation of Telomerase—TGFB1—systemic scleroderma	0.000197	0.0014	CbGpPWpGaD
Melatonin—Asthenia—Methotrexate—systemic scleroderma	0.000193	0.000486	CcSEcCtD
Melatonin—ESR1—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000192	0.00137	CbGpPWpGaD
Melatonin—Nausea—Prednisone—systemic scleroderma	0.000191	0.000481	CcSEcCtD
Melatonin—Pruritus—Methotrexate—systemic scleroderma	0.00019	0.000479	CcSEcCtD
Melatonin—CYP19A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000184	0.00131	CbGpPWpGaD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000178	0.00127	CbGpPWpGaD
Melatonin—Dizziness—Methotrexate—systemic scleroderma	0.000178	0.000448	CcSEcCtD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000177	0.00126	CbGpPWpGaD
Melatonin—Vomiting—Methotrexate—systemic scleroderma	0.000171	0.000431	CcSEcCtD
Melatonin—Rash—Methotrexate—systemic scleroderma	0.000169	0.000427	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—systemic scleroderma	0.000169	0.000427	CcSEcCtD
Melatonin—CALM1—Endochondral Ossification—MMP9—systemic scleroderma	0.000169	0.0012	CbGpPWpGaD
Melatonin—CALM2—Endochondral Ossification—MMP9—systemic scleroderma	0.000169	0.0012	CbGpPWpGaD
Melatonin—Headache—Methotrexate—systemic scleroderma	0.000168	0.000424	CcSEcCtD
Melatonin—ASMT—Metabolism—NOS3—systemic scleroderma	0.000164	0.00117	CbGpPWpGaD
Melatonin—Nausea—Methotrexate—systemic scleroderma	0.00016	0.000402	CcSEcCtD
Melatonin—CALM2—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.000157	0.00112	CbGpPWpGaD
Melatonin—CALM1—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.000157	0.00112	CbGpPWpGaD
Melatonin—CALM3—Alzheimers Disease—IL1B—systemic scleroderma	0.000157	0.00111	CbGpPWpGaD
Melatonin—CALM1—Alzheimers Disease—IL1B—systemic scleroderma	0.000152	0.00108	CbGpPWpGaD
Melatonin—CALM2—Alzheimers Disease—IL1B—systemic scleroderma	0.000152	0.00108	CbGpPWpGaD
Melatonin—ESR1—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000149	0.00106	CbGpPWpGaD
Melatonin—IDO1—Metabolism—NOS3—systemic scleroderma	0.000146	0.00104	CbGpPWpGaD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000146	0.00104	CbGpPWpGaD
Melatonin—CALM3—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.000145	0.00103	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—SELP—systemic scleroderma	0.000144	0.00102	CbGpPWpGaD
Melatonin—MTNR1A—Signaling by GPCR—CCL2—systemic scleroderma	0.000143	0.00102	CbGpPWpGaD
Melatonin—MTNR1B—Signaling by GPCR—CCL2—systemic scleroderma	0.000143	0.00102	CbGpPWpGaD
Melatonin—CALM1—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.00014	0.000993	CbGpPWpGaD
Melatonin—CALM2—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.00014	0.000993	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.00014	0.000991	CbGpPWpGaD
Melatonin—CALM2—Endochondral Ossification—TGFB1—systemic scleroderma	0.000139	0.000991	CbGpPWpGaD
Melatonin—CALM1—Endochondral Ossification—TGFB1—systemic scleroderma	0.000139	0.000991	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—SELP—systemic scleroderma	0.000139	0.000987	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—SELP—systemic scleroderma	0.000139	0.000987	CbGpPWpGaD
Melatonin—CALM3—Signaling by VEGF—NOS3—systemic scleroderma	0.000136	0.000969	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000134	0.000955	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—RHOB—systemic scleroderma	0.000134	0.000952	CbGpPWpGaD
Melatonin—CALM2—Signaling by VEGF—NOS3—systemic scleroderma	0.000132	0.000938	CbGpPWpGaD
Melatonin—CALM1—Signaling by VEGF—NOS3—systemic scleroderma	0.000132	0.000938	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—RHOB—systemic scleroderma	0.00013	0.000921	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—RHOB—systemic scleroderma	0.00013	0.000921	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—SMAD7—systemic scleroderma	0.000129	0.000919	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—EDN1—systemic scleroderma	0.000124	0.000878	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—EDN1—systemic scleroderma	0.000124	0.000878	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—CSK—systemic scleroderma	0.000122	0.000867	CbGpPWpGaD
Melatonin—CALM3—Platelet degranulation—TGFB1—systemic scleroderma	0.000121	0.000857	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—TNFSF13—systemic scleroderma	0.00012	0.000855	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—CSK—systemic scleroderma	0.000118	0.000839	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—CSK—systemic scleroderma	0.000118	0.000839	CbGpPWpGaD
Melatonin—CALM2—Platelet degranulation—TGFB1—systemic scleroderma	0.000117	0.000829	CbGpPWpGaD
Melatonin—CALM1—Platelet degranulation—TGFB1—systemic scleroderma	0.000117	0.000829	CbGpPWpGaD
Melatonin—CALM3—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000115	0.000816	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—ITGAM—systemic scleroderma	0.000115	0.000816	CbGpPWpGaD
Melatonin—CALR—Disease—NOS3—systemic scleroderma	0.000115	0.000815	CbGpPWpGaD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000114	0.000807	CbGpPWpGaD
Melatonin—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000112	0.000797	CbGpPWpGaD
Melatonin—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000112	0.000797	CbGpPWpGaD
Melatonin—CALM1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000111	0.00079	CbGpPWpGaD
Melatonin—CALM2—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000111	0.00079	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—ITGAM—systemic scleroderma	0.000111	0.000789	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—ITGAM—systemic scleroderma	0.000111	0.000789	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000109	0.000776	CbGpPWpGaD
Melatonin—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000107	0.000763	CbGpPWpGaD
Melatonin—CALR—Immune System—IL1B—systemic scleroderma	0.000106	0.000751	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CSK—systemic scleroderma	0.000106	0.00075	CbGpPWpGaD
Melatonin—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000104	0.000738	CbGpPWpGaD
Melatonin—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000104	0.000738	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CD247—systemic scleroderma	0.000103	0.000734	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—ITGAM—systemic scleroderma	0.000103	0.000734	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CSK—systemic scleroderma	0.000102	0.000725	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CSK—systemic scleroderma	0.000102	0.000725	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—ITGAM—systemic scleroderma	0.0001	0.00071	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CD247—systemic scleroderma	0.0001	0.00071	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CD247—systemic scleroderma	0.0001	0.00071	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—ITGAM—systemic scleroderma	0.0001	0.00071	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD247—systemic scleroderma	9.92e-05	0.000705	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—TNFAIP3—systemic scleroderma	9.68e-05	0.000688	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD247—systemic scleroderma	9.6e-05	0.000682	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD247—systemic scleroderma	9.6e-05	0.000682	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—TNFAIP3—systemic scleroderma	9.36e-05	0.000665	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—TNFAIP3—systemic scleroderma	9.36e-05	0.000665	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—BLK—systemic scleroderma	9.18e-05	0.000652	CbGpPWpGaD
Melatonin—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	9.14e-05	0.00065	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.93e-05	0.000635	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—BLK—systemic scleroderma	8.88e-05	0.000631	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—BLK—systemic scleroderma	8.88e-05	0.000631	CbGpPWpGaD
Melatonin—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	8.84e-05	0.000628	CbGpPWpGaD
Melatonin—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	8.84e-05	0.000628	CbGpPWpGaD
Melatonin—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	8.61e-05	0.000612	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—CCL2—systemic scleroderma	8.45e-05	0.0006	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—CCL2—systemic scleroderma	8.45e-05	0.0006	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SMAD7—systemic scleroderma	8.41e-05	0.000598	CbGpPWpGaD
Melatonin—CALM3—Disease—SMAD7—systemic scleroderma	8.39e-05	0.000596	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	8.27e-05	0.000588	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—HSPG2—systemic scleroderma	8.2e-05	0.000583	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.15e-05	0.000579	CbGpPWpGaD
Melatonin—CALM1—Disease—SMAD7—systemic scleroderma	8.11e-05	0.000577	CbGpPWpGaD
Melatonin—CALM2—Disease—SMAD7—systemic scleroderma	8.11e-05	0.000577	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—HSPG2—systemic scleroderma	7.9e-05	0.000561	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—RHOB—systemic scleroderma	7.69e-05	0.000547	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFBI—systemic scleroderma	7.67e-05	0.000545	CbGpPWpGaD
Melatonin—CALR—Disease—TGFB1—systemic scleroderma	7.58e-05	0.000539	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—NOS3—systemic scleroderma	7.53e-05	0.000535	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—NOS3—systemic scleroderma	7.53e-05	0.000535	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	7.52e-05	0.000534	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	7.44e-05	0.000529	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	7.44e-05	0.000529	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFBI—systemic scleroderma	7.42e-05	0.000527	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFBI—systemic scleroderma	7.42e-05	0.000527	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	7.27e-05	0.000517	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	7.27e-05	0.000517	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—CTGF—systemic scleroderma	7.15e-05	0.000508	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.96e-05	0.000495	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.77e-05	0.000481	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—RHOB—systemic scleroderma	6.51e-05	0.000462	CbGpPWpGaD
Melatonin—CALM3—Immune System—CSK—systemic scleroderma	6.4e-05	0.000455	CbGpPWpGaD
Melatonin—CALM3—Immune System—IRF5—systemic scleroderma	6.3e-05	0.000447	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—CTGF—systemic scleroderma	6.21e-05	0.000442	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	6.19e-05	0.00044	CbGpPWpGaD
Melatonin—CALM2—Immune System—CSK—systemic scleroderma	6.19e-05	0.00044	CbGpPWpGaD
Melatonin—CALM1—Immune System—CSK—systemic scleroderma	6.19e-05	0.00044	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.17e-05	0.000439	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HSPG2—systemic scleroderma	6.14e-05	0.000436	CbGpPWpGaD
Melatonin—CALM3—Disease—HSPG2—systemic scleroderma	6.12e-05	0.000435	CbGpPWpGaD
Melatonin—CALM2—Immune System—IRF5—systemic scleroderma	6.09e-05	0.000433	CbGpPWpGaD
Melatonin—CALM1—Immune System—IRF5—systemic scleroderma	6.09e-05	0.000433	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—MMP9—systemic scleroderma	6.04e-05	0.000429	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—MMP9—systemic scleroderma	6.04e-05	0.000429	CbGpPWpGaD
Melatonin—CALM3—Immune System—IRF8—systemic scleroderma	6.02e-05	0.000428	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD247—systemic scleroderma	6.02e-05	0.000428	CbGpPWpGaD
Melatonin—CALM3—Immune System—ITGAM—systemic scleroderma	6.02e-05	0.000428	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	5.99e-05	0.000426	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	5.99e-05	0.000426	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—CTGF—systemic scleroderma	5.98e-05	0.000425	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CSK—systemic scleroderma	5.93e-05	0.000421	CbGpPWpGaD
Melatonin—CALM1—Disease—HSPG2—systemic scleroderma	5.92e-05	0.000421	CbGpPWpGaD
Melatonin—CALM2—Disease—HSPG2—systemic scleroderma	5.92e-05	0.000421	CbGpPWpGaD
Melatonin—CALM3—Disease—CSK—systemic scleroderma	5.91e-05	0.00042	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	5.87e-05	0.000417	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	5.85e-05	0.000416	CbGpPWpGaD
Melatonin—CALM2—Immune System—IRF8—systemic scleroderma	5.82e-05	0.000414	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD247—systemic scleroderma	5.82e-05	0.000414	CbGpPWpGaD
Melatonin—CALM1—Immune System—IRF8—systemic scleroderma	5.82e-05	0.000414	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD247—systemic scleroderma	5.82e-05	0.000414	CbGpPWpGaD
Melatonin—CALM2—Immune System—ITGAM—systemic scleroderma	5.82e-05	0.000414	CbGpPWpGaD
Melatonin—CALM1—Immune System—ITGAM—systemic scleroderma	5.82e-05	0.000414	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—MMP1—systemic scleroderma	5.75e-05	0.000409	CbGpPWpGaD
Melatonin—CALM2—Disease—CSK—systemic scleroderma	5.72e-05	0.000406	CbGpPWpGaD
Melatonin—CALM1—Disease—CSK—systemic scleroderma	5.72e-05	0.000406	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	5.68e-05	0.000404	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	5.68e-05	0.000404	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	5.66e-05	0.000402	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	5.66e-05	0.000402	CbGpPWpGaD
Melatonin—CALM3—Immune System—TNFAIP3—systemic scleroderma	5.64e-05	0.0004	CbGpPWpGaD
Melatonin—CALM3—Immune System—BLK—systemic scleroderma	5.57e-05	0.000396	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—MMP1—systemic scleroderma	5.56e-05	0.000395	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—MMP1—systemic scleroderma	5.56e-05	0.000395	CbGpPWpGaD
Melatonin—CALM3—Disease—CD247—systemic scleroderma	5.56e-05	0.000395	CbGpPWpGaD
Melatonin—CALM1—Immune System—TNFAIP3—systemic scleroderma	5.45e-05	0.000387	CbGpPWpGaD
Melatonin—CALM2—Immune System—TNFAIP3—systemic scleroderma	5.45e-05	0.000387	CbGpPWpGaD
Melatonin—CALM1—Immune System—BLK—systemic scleroderma	5.39e-05	0.000383	CbGpPWpGaD
Melatonin—CALM2—Immune System—BLK—systemic scleroderma	5.39e-05	0.000383	CbGpPWpGaD
Melatonin—CALM1—Disease—CD247—systemic scleroderma	5.37e-05	0.000382	CbGpPWpGaD
Melatonin—CALM2—Disease—CD247—systemic scleroderma	5.37e-05	0.000382	CbGpPWpGaD
Melatonin—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	5.35e-05	0.00038	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5.28e-05	0.000375	CbGpPWpGaD
Melatonin—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	5.17e-05	0.000368	CbGpPWpGaD
Melatonin—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	5.17e-05	0.000368	CbGpPWpGaD
Melatonin—CALM3—Metabolism—HSPG2—systemic scleroderma	5.12e-05	0.000364	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TGFB1—systemic scleroderma	4.98e-05	0.000354	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TGFB1—systemic scleroderma	4.98e-05	0.000354	CbGpPWpGaD
Melatonin—CALM2—Metabolism—HSPG2—systemic scleroderma	4.96e-05	0.000352	CbGpPWpGaD
Melatonin—CALM1—Metabolism—HSPG2—systemic scleroderma	4.96e-05	0.000352	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—HSPG2—systemic scleroderma	4.86e-05	0.000346	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTLA4—systemic scleroderma	4.56e-05	0.000324	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RHOB—systemic scleroderma	4.54e-05	0.000323	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTLA4—systemic scleroderma	4.41e-05	0.000314	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTLA4—systemic scleroderma	4.41e-05	0.000314	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RHOB—systemic scleroderma	4.4e-05	0.000312	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RHOB—systemic scleroderma	4.4e-05	0.000312	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	4.28e-05	0.000304	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—NOS3—systemic scleroderma	4.17e-05	0.000296	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	4.14e-05	0.000295	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	4.14e-05	0.000295	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CSK—systemic scleroderma	4.14e-05	0.000294	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—NOS3—systemic scleroderma	4.03e-05	0.000287	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—NOS3—systemic scleroderma	4.03e-05	0.000287	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CSK—systemic scleroderma	4e-05	0.000284	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CSK—systemic scleroderma	4e-05	0.000284	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—HSPG2—systemic scleroderma	3.98e-05	0.000283	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	3.93e-05	0.000279	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CTGF—systemic scleroderma	3.88e-05	0.000276	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	3.8e-05	0.00027	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	3.8e-05	0.00027	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CTGF—systemic scleroderma	3.76e-05	0.000267	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CTGF—systemic scleroderma	3.76e-05	0.000267	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-DQB1—systemic scleroderma	3.76e-05	0.000267	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CTGF—systemic scleroderma	3.68e-05	0.000262	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-DQB1—systemic scleroderma	3.63e-05	0.000258	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-DQB1—systemic scleroderma	3.63e-05	0.000258	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—HSPG2—systemic scleroderma	3.63e-05	0.000258	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL1A—systemic scleroderma	3.57e-05	0.000253	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD40LG—systemic scleroderma	3.55e-05	0.000252	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL1A—systemic scleroderma	3.45e-05	0.000245	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL1A—systemic scleroderma	3.45e-05	0.000245	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD40LG—systemic scleroderma	3.43e-05	0.000244	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD40LG—systemic scleroderma	3.43e-05	0.000244	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EDN1—systemic scleroderma	3.32e-05	0.000236	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HSPG2—systemic scleroderma	3.1e-05	0.00022	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CTGF—systemic scleroderma	3.02e-05	0.000214	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TGFB1—systemic scleroderma	2.76e-05	0.000196	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CTGF—systemic scleroderma	2.75e-05	0.000195	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—NOS3—systemic scleroderma	2.7e-05	0.000192	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	2.68e-05	0.000191	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TGFB1—systemic scleroderma	2.67e-05	0.00019	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TGFB1—systemic scleroderma	2.67e-05	0.00019	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—NOS3—systemic scleroderma	2.6e-05	0.000185	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	2.6e-05	0.000185	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	2.6e-05	0.000185	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CTGF—systemic scleroderma	2.35e-05	0.000167	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EDN1—systemic scleroderma	2.32e-05	0.000165	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCL2—systemic scleroderma	2.27e-05	0.000161	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EDN1—systemic scleroderma	2.24e-05	0.000159	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EDN1—systemic scleroderma	2.24e-05	0.000159	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NOS3—systemic scleroderma	2.02e-05	0.000144	CbGpPWpGaD
Melatonin—CALM3—Disease—NOS3—systemic scleroderma	2.02e-05	0.000143	CbGpPWpGaD
Melatonin—CALM2—Disease—NOS3—systemic scleroderma	1.95e-05	0.000139	CbGpPWpGaD
Melatonin—CALM1—Disease—NOS3—systemic scleroderma	1.95e-05	0.000139	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL1B—systemic scleroderma	1.86e-05	0.000132	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL1B—systemic scleroderma	1.8e-05	0.000128	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL1B—systemic scleroderma	1.8e-05	0.000128	CbGpPWpGaD
Melatonin—CALM3—Metabolism—NOS3—systemic scleroderma	1.69e-05	0.00012	CbGpPWpGaD
Melatonin—CALM2—Metabolism—NOS3—systemic scleroderma	1.64e-05	0.000116	CbGpPWpGaD
Melatonin—CALM1—Metabolism—NOS3—systemic scleroderma	1.64e-05	0.000116	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—systemic scleroderma	1.62e-05	0.000115	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—NOS3—systemic scleroderma	1.6e-05	0.000114	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCL2—systemic scleroderma	1.59e-05	0.000113	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL2—systemic scleroderma	1.53e-05	0.000109	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL2—systemic scleroderma	1.53e-05	0.000109	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOS3—systemic scleroderma	1.41e-05	0.0001	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOS3—systemic scleroderma	1.37e-05	9.72e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOS3—systemic scleroderma	1.37e-05	9.72e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—systemic scleroderma	1.34e-05	9.51e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—systemic scleroderma	1.33e-05	9.48e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NOS3—systemic scleroderma	1.31e-05	9.33e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—systemic scleroderma	1.29e-05	9.17e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—systemic scleroderma	1.29e-05	9.17e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NOS3—systemic scleroderma	1.2e-05	8.5e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—systemic scleroderma	1.13e-05	8.06e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—systemic scleroderma	1.1e-05	7.8e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—systemic scleroderma	1.1e-05	7.8e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NOS3—systemic scleroderma	1.02e-05	7.27e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	9.35e-06	6.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	9.04e-06	6.42e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	9.04e-06	6.42e-05	CbGpPWpGaD
